Hyperfine SPAC Presentation Deck

Valuation benchmarking Merger price set at a discount to similar high growth and disruptive companies to incentivize current and new stakeholders to maximize impact High Growth Med-Tech Disruptive Technologies Butterfly INARI Inspire pulmonX SHOCKWAVE SILKROAD> MEDICAL 10x GENOMICS AbCellera biotechnologies HYPERFINE © 2021 Hyperfine, Inc. Source: Based on Capital IQ, public filings and analyst estimates (Butterfly valuation from company estimates) as of 07/06/21 BERKELEY LIGHTS 7 GUARDANT Median EV/ Revenue 2023E 12.7x 17.9x 10.7x Revenue CAGR 2021-2023E 37.9% 33.7% 384.4% HYPERFINE

View entire presentation